IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 306 filers reported holding IONIS PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,235,056 | +15.2% | 159,503 | +4.2% | 1.33% | +21.8% |
| Q2 2023 | $6,279,724 | +16.2% | 153,052 | +1.3% | 1.09% | -7.3% |
| Q1 2023 | $5,402,494 | +1.4% | 151,161 | +7.1% | 1.18% | -17.2% |
| Q4 2022 | $5,329,914 | -50.2% | 141,115 | -41.7% | 1.42% | -53.4% |
| Q3 2022 | $10,701,000 | +65.8% | 241,945 | +38.8% | 3.04% | +28.0% |
| Q2 2022 | $6,453,000 | +164.3% | 174,300 | +117.2% | 2.38% | +340.8% |
| Q4 2021 | $2,442,000 | -46.6% | 80,238 | -41.2% | 0.54% | -53.4% |
| Q3 2021 | $4,574,000 | -15.9% | 136,380 | 0.0% | 1.16% | -2.7% |
| Q2 2021 | $5,440,000 | +14.4% | 136,380 | +28.9% | 1.19% | +7.7% |
| Q1 2021 | $4,757,000 | +11.6% | 105,797 | +40.3% | 1.10% | +1.1% |
| Q4 2020 | $4,264,000 | – | 75,418 | – | 1.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |